These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32183488)

  • 21. L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness.
    Wang J; Li D; Bambara RA; Yang H; Dykes C
    J Gen Virol; 2013 Jul; 94(Pt 7):1597-1607. PubMed ID: 23535575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors.
    Kang D; Urhan Ç; Wei F; Frutos-Beltrán E; Sun L; Álvarez M; Feng D; Tao Y; Pannecouque C; De Clercq E; Menéndez-Arias L; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113769. PubMed ID: 34403976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H.
    Corona A; di Leva FS; Rigogliuso G; Pescatori L; Madia VN; Subra F; Delelis O; Esposito F; Cadeddu M; Costi R; Cosconati S; Novellino E; di Santo R; Tramontano E
    Antiviral Res; 2016 Oct; 134():236-243. PubMed ID: 27659398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H.
    Kang JX; Zhao GK; Yang XM; Huang MX; Hui WQ; Zeng R; Ouyang Q
    Eur J Med Chem; 2023 Mar; 250():115196. PubMed ID: 36787657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaffold hopping and optimisation of 3',4'-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H.
    Tocco G; Esposito F; Caboni P; Laus A; Beutler JA; Wilson JA; Corona A; Le Grice SFJ; Tramontano E
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1953-1963. PubMed ID: 33143469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV-1 ribonuclease H activity by novel frangula-emodine derivatives.
    Tatyana K; Francesca E; Luca Z; Giovanni F; Cheng YC; Ginger ED; Enzo T
    Med Chem; 2009 Sep; 5(5):398-410. PubMed ID: 19534674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
    Tang J; Liu F; Nagy E; Miller L; Kirby KA; Wilson DJ; Wu B; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2016 Mar; 59(6):2648-59. PubMed ID: 26927866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.
    Hisayoshi T; Shinomura M; Yokokawa K; Kuze I; Konishi A; Kawaji K; Kodama EN; Hata K; Takahashi S; Nirasawa S; Sakuda S; Yasukawa K
    J Nat Med; 2015 Jul; 69(3):432-40. PubMed ID: 25663480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.
    Corona A; Di Leva FS; Thierry S; Pescatori L; Cuzzucoli Crucitti G; Subra F; Delelis O; Esposito F; Rigogliuso G; Costi R; Cosconati S; Novellino E; Di Santo R; Tramontano E
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6101-10. PubMed ID: 25092689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors.
    Esposito F; Sechi M; Pala N; Sanna A; Koneru PC; Kvaratskhelia M; Naesens L; Corona A; Grandi N; di Santo R; D'Amore VM; Di Leva FS; Novellino E; Cosconati S; Tramontano E
    Antiviral Res; 2020 Feb; 174():104671. PubMed ID: 31812637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
    Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
    Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
    Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
    ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
    Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
    J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.